ArticleJournal of blood medicine2023

Switching from Sucrose-Formulated rFVIII to Octocog Alfa (BAY 81-8973) Prophylaxis Improves Bleed Outcomes in the LEOPOLD Clinical Trials.

Gili Kenet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.